Fiebo J.W. ten Kate

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · The Lancet Oncology · 2015 · 2.5K citations

Surgical Oncology, Neoadjuvant Chemoradiotherapy, Esophageal Cancer +9

Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus

Jan B.F. Hulscher, Johanna W. van Sandick, Angela G. E. M. de Boer et al. · New England Journal of Medicine · 2002 · 1.6K citations · Full text

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

Ben M. Eyck, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · Journal of Clinical Oncology · 2021 · 709 citations · Full text

Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus

Jikke M.T. Omloo, Sjoerd M. Lagarde, Jan B.F. Hulscher et al. · Annals of Surgery · 2007 · 705 citations

Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia

K. Nadine Phoa, Frederike G.I. van Vilsteren, Bas L. Weusten et al. · JAMA · 2014 · 627 citations · Full text